Covered recipient · General Payments record
BRIAN C GARTRELL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$981.01
- Reported across 63 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $195.81 | 12 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $62.22 | 4 |
| Novo Nordisk AS | $50.27 | 3 |
| Amgen Inc. | $28.95 | 2 |
| Acerta Pharma LLC | $21.85 | 1 |
| Lilly USA, LLC | $16.93 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.52 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201906056 | CMS |
| ABBVIE INC. | $13.83 | 05/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201906058 | CMS |
| ABBVIE INC. | $16.21 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201906060 | CMS |
| ABBVIE INC. | $16.66 | 10/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201906062 | CMS |
| Amgen Inc. | $15.07 | 01/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228412881 | CMS |
| Amgen Inc. | $13.88 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227092175 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.85 | 06/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206604221 | CMS |
| Lilly USA, LLC | $16.93 | 12/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186482135 | CMS |
| Novo Nordisk Inc | $14.57 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188783221 | CMS |
| Novo Nordisk Inc | $16.98 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188674648 | CMS |
| Novo Nordisk Inc | $18.72 | 10/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188156947 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.59 | 10/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223822840 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.